Brought to you by 
Check-Cap nets $10.9mm through private placement concurrent with IPO
23 Feb 2015
Executive Summary
Concurrent with the closing of its initial public offering in the US, Israeli diagnostic imaging firm Check-Cap Ltd. netted $10.9mm through a private placement of 2mm ordinary shares at the IPO price ($6). Investors also received 1mm five-year Series A warrants to purchase ordinary shares at $7.50, and 3mm long-term incentive warrants which, when vested, allow for the purchase of ordinary shares at $6.90; the long-term incentive warrants expire in 2022.
Deal Industry
- Medical Devices
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- X-ray
-
Diagnostic Imaging Equipment & Supplies
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Check-Cap nets $10.9mm through private placement concurrent with IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice